Trinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq ...

Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...

Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ETCompany ParticipantsJoanne Freiberger - Senior Vice President ...

Researchers have determined that in comparison to insulin treatment, the use of a strategy of oral glucose-lowering agents ...

Horizon Kinetics have published their Q4 2024 Commentary. How’d we do? How’d the market do? What to expect now? Click here to ...

This important study shows that the activity of hypothalamic hypocretin/orexin neurons (HONs) correlates with body movement over multiple behaviors. Sophisticated techniques and analyses showcase this ...

Mastering neutral market strategies gives you the flexibility to adapt, reduce risk, and find opportunities others overlook.

The selection of Zeev Buium (who I believe is one of the top prospects in the sport right now) 12th in 2024 and the addition ...

Plus Moritz Seider’s easing burden in Detroit, home-ice disadvantage in Utah, how multiple teams have adjusted amidst ...